On April 30-May 2, California’s cannabis leaders will converge in Canada, bringing decades of experience in cultivating a legal cannabis industry from the underground up. California is now the biggest legalization market in the world, expected to hit $3.7 billion in 2018, and increase to over $5 billion in 2019. As Canada moves into legalization, investors survey industry veterans as opportunities flood the market. To that end ArcView Group, the first-ever cannabis investment and research firm, will hold an international investor forum in Vancouver, B.C., featuring ArcView co-founder and President Steve DeAngelo. The longtime visionary-entrepreneur is also co-founder of Harborside.
With over 300,000 customers, Harborside is the most recognized cannabis retail brand in the U.S. and abroad, and has long been considered the premier model for cannabis retail. Investors seeking greater opportunities with established companies have expressed much interest in Harborside and its parent, FLRish, Inc., one of the leading vertically integrated cannabis companies in California. This worldwide moment merging cannabis commerce with culture is a tipping point for DeAngelo, who’s been on the forefront of ending prohibition his entire adult life.
“The only way cannabis will make it into the medicine chest of every family around the world is if you engage with the global business infrastructure,” said DeAngelo in Institutional Investor (Nov. 2017), which called DeAngelo the “mogul of marijuana.”
DeAngelo is currently FLRish’s Chairman Emeritus. DeAngelo is also the co-founder of Steep Hill Labs, the leading global provider of cannabis testing and analytics; and author of The Cannabis Manifesto: A New Paradigm for Wellness. DeAngelo was named one of the most influential people and “gatekeeper” of the marijuana industry in 2015 by the International Business Times, one of the United States’ most powerful leaders in the cannabis industry by Fortune Magazine in 2016, and was awarded the High Times Lester Grinspoon Lifetime Achievement Award in recognition for his four decades of activism in the cannabis reform movement.
A popular and influential speaker, DeAngelo recently gave keynotes at CannaTech Israel, Prague’s global cannabis conference, and appeared at Oxford University, winning the Oxford Union Debates in 2017; he was recently the keynote at San Francisco’s prestigious Pacific Union Club. DeAngelo’s appearances and pioneering successes have drawn attention from investors around the globe. The growing significance of the California market, and brands being developed there, are becoming more apparent every day. Canadian companies are now investing heavily in the U.S., especially in California, and for good reason.
WHAT: The ArcView Group cannabis investment forum with Steve DeAngelo
WHERE: The Westin Bayshore, Vancouver, B.C.WHEN: April 30 – May 2, 2018
“Harborside, a medical marijuana dispensary with locations in Oakland and San Jose, California, is looked upon as a model of how others could operate.” – The New York Times
Founded in the 2006 by Steve DeAngelo, Harborside was the first cannabis dispensary in the nation to form a lab to test cannabis; first to support education for seniors, veterans, and families with severely ill children; first in the country to offer CBD-rich medicine; and the first to treat children with Dravet syndrome. With locations in Oakland, San Jose and (coming soon) San Leandro, Calif., Harborside continues to set an example of diversity and compliance, and is one of the prime advocates of sustainability and economic justice in the industry as part of its core mission. In 2017 Harborside was awarded “Best Dispensary” in California by the San Francisco Chronicle.